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Abstract
To investigate whether procalcitonin (PCT) can improve the performance of quick sequential organ failure assessment (SOFA) score
in predicting sepsis mortality, we conducted a retrospective multicenter cohort study with independent validation in a prospectively
collected cohort in 3 tertiary medical centers. Patients with presumed sepsis were included. Serum PCT levels were measured at
admission. Quick SOFA score and systemic inflammatory response syndrome (SIRS) criteria were calculated for each patient. PCT
levels were assigned into 0, 1, and 2 points for a serum level of <0.25, 0.25 to 2, and >2ng/mL, and added to the quick sepsis-
related organ failure assessment (qSOFA) score. The incremental value of PCT to qSOFA was then evaluated by logistic regression,
receiver-operating characteristic (ROC) curve, and reclassification analysis.
In all, 1318 patients with presumed severe infection were enrolled with a 30-day mortality of 13.5%. Serum level of PCT showed a
high correlation with qSOFA score and 30-day inhospital mortality. The area under the ROC curve was 0.56 for SIRS criteria, 0.67 for
qSOFA score, and 0.73 for qSOFA_PCT in predicting 30-day mortality. The risk prediction improvement was reflected by a net
reclassification improvement of 35% (17%–52%). Incorporation of PCT into the qSOFA model could raise the sensitivity to 86.5%
(95% confidence interval 80.6%–91.2%). In the validation cohort, qSOFA_PCT greatly improved the sensitivity to 90.9%.
A simple modification of qSOFA score by adding the ordinal scale of PCT value to qSOFA could greatly improve the suboptimal
sensitivity problem of qSOFA and may serve as a quick screening tool for early identification of sepsis.
Abbreviations: AUC = area under the curve, CRP = C-reactive protein, ED = emergency department, FSFPH = First People’s
Hospital of Foshan, ICU= intensive care unit, IDI= integrated discrimination improvement, NPV= negative predictive value, NRI= net
reclassification improvement, NTUH = National Taiwan University Hospital Yunlin Branch, PCT = procalcitonin, PPV = positive
predictive value, qSOFA = quick sepsis-related organ failure assessment, ROC curve = receiver-operating characteristic curve,
SCPH = Sichuan Provincial People Hospital, SIRS = systemic inflammatory response syndrome, SOFA = sequential organ failure
assessment, WBC = white blood cell.
Keywords: procalcitonin, qSOFA, quick SOFA score, sepsis
1. Introduction
Sepsis is a leading cause of mortality and morbidity globally.[1–4]
Early diagnosis of sepsis and early initiation of evidence-based
bundle care can greatly improve the outcome of sepsis.
Unfortunately, early and accurate diagnosis of sepsis is difficult.
Sepsis is a complex clinical syndrome with a wide range of
manifestations. Although the systemic inflammatory response
syndrome (SIRS) criteria were part of the prior definition of sepsis,
it has been shown to be unable to differentiate severe from
uncomplicated infections. The latest Sepsis-3 definition describes
sepsis as a life-threatening organ dysfunction caused by a
dysregulated host response to infection,[5,6] with life-threatening
organ dysfunction defined as a change in the sequential organ
failure assessment (SOFA) score of more than 2 points in intensive
care unit (ICU) patients.[7–9] In clinical settings outside the ICU
where calculating the SOFA score is not routine, a simplified score
—quick sepsis-related organ failure assessment (qSOFA)—was
introduced as a screening tool for patients with sepsis.[10]
Since the introduction of qSOFA, concerns have been raised.
None of the elements in qSOFA are specific for the detection of
infection, and subsequent validation studies showed suboptimal
overall discrimination and sensitivity (reported sensitivity 32%)
under the recommended cut-off.[11] In addition, diagnosing sepsis
relies on the accuracy of the physician’s clinical suspicion of
infection.[12] Infectious disease biomarkers such as C-reactive
protein (CRP) and procalcitonin (PCT), on the contrary, have
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been shown to accurately predict infection and mortality.[13]
These 2markers were accepted as part of the diagnostic criteria in
Sepsis-2, but were not included in the Sepsis-3 definition.[13,14]
Thus, combining biomarker information with the qSOFA score
would potentially enhance its ability to predict the mortality risk
from sepsis. In this study, we sought to evaluate whether adding
either CRP or PCT to the qSOFA score would improve its ability
to predict inhospital mortality in a multicenter cohort of patients
who presented with clinical symptoms of systemic infection.
2. Methods
2.1. Study design and locations
This was a multicenter retrospective cohort study performed at
the Sichuan Provincial People Hospital (SCPH) in Chengdu City,
First People’s Hospital of Foshan (FSFPH) in Guangdong
province of China, and National Taiwan University Hospital
Yunlin Branch (NTUH) in Douliou city. All 3 hospitals are
tertiary-care urban medical centers.
2.2. Study population
Patients were enrolled retrospectively using consecutive sampling
of cases from each hospital from January 1, 2015 to December
31, 2016. All adult patients (≥18 years old) who presented to the
emergency department or were admitted to the hospital floor
were eligible for inclusion. Patients were included if they had
symptoms that indicated systemic infection; and PCT (VIDAS
BRAHMS PCT) and blood culture tests within 24hours of
admission. Exclusion criteria were missing data, transfer from
other hospitals, leucopenia, do-not-resuscitate (DNR) orders, lost
to follow-up, or history of pre-existing thyroid disease that may
affect procalcitonin levels. Participating investigators from the 3
sites independently reviewed all retrieved medical records to
confirm the presence of infection as a reason for admission. The
study focused on qSOFA score, which targeted the sepsis patients
outside the ICU. Therefore, we excluded patients who developed
sepsis in ICU. A cohort that prospectively collected 493
consecutive emergency department (ED) patients with presumed
sepsis was used for independent validation. Patients with
presumed sepsis was defined patients who fulfilled at least 2 of
the 3 SIRS criteria (temperature >38°C or<36°C, pulse rate ≥90
beats per minute, and respiratory rate ≥20/min) upon ED
admission with a presumed diagnosis of systemic infection by
treating physicians. This study was approved by the Research
Committees and Institutional Review Boards for all institutions,
and it met criteria for exemption from informed consent.
2.3. Data collection
The hospitalization course of all patients was followed from
admission to discharge. Using a standardized data collection
instrument, data were collected on patients (Table 1). The worst
physiological and laboratory measurements within the initial 24
Table 1
Characteristics of the derivation cohort from 3 participating hospitals from 2015 to 2016.
Variables Total Survivor (n=1140) Nonsurvivor (n=178) P
Sex (male %) 826 (62.7%) 708 (62.2%) 118 (66.3%) .289
Age
Age, median (interquartile range) 64 (47–75) 62 (47–74) 71 (55–81) <.0001
Age, ≥65 y 611 (46.4%) 505 (44.3%) 106 (59.6%) <.0001
Nursing home residents 73 (5.5%) 57 (5.0%) 16 (9.0%) .030
Comorbidities
Diabetes mellitus 300 (22.8%) 253 (22.2%) 47 (26.4%) .213
Malignancies 102 (7.7%) 76 (6.7%) 26 (14.6%) <.0001
Hemiplegic stroke 41 (3.1%) 30 (2.6%) 11 (6.2%) .011
Previous myocardial infarction 39 (3.0%) 28 (2.5%) 11 (6.2%) .006
Chronic liver disease 17 (9.6%) 84 (6.4%) 67 (5.9%) .062
Terminal illness (<30 d) 26 (14.6%) 69 (4.5%) 43 (3.8%) <.0001
Site of primary infection
Lower respiratory tract infection 712 (54.0%) 599 (52.5%) 113 (63.5%) .006
Urinary tract infection 143 (10.8%) 128 (11.2%) 15 (8.4%) .264
Skin and musculoskeletal infection 40 (3.0%) 33 (2.9%) 7 (3.9%) .706
Primary bacteremia 59 (3.9%) 52 (4.4%) 7 (5.9%) .520
Hepatobiliary infection 50 (3.8%) 47 (4.1%) 3 (1.7%) .113
Intra-abdomen infection 88 (6.7%) 74 (6.5%) 14 (7.9%) .495
Organ dysfunction
Altered consciousness 237 (18.0%) 168 (14.7%) 69 (38.8%) <.001
Acute respiratory failure 441 (30.4%) 344 (30.2%) 97 (54.5%) <.001
Acute renal failure 203 (15.4%) 155 (13.6%) 48 (27.0%) <.001
Septic shock 362 (14.9%) 278 (24.3%) 84 (47.2%) <.001
Laboratory results
Procalcitoninemia (PCT >0.25ng/mL) 935 (70.9%) 772 (67.7%) 163 (91.6%) <.001
C-reactive protein
∗
(CRP >60mg/L) 532 (48.8%) 460 (48.4%) 72 (51.4%) .506
Bacteremia 205 (15.6%) 165 (14.5%) 40 (22.5%) .006
Gram-positive 81 (6.1%) 65 (5.7%) 16 (9.0%) .099
Gram-negative 94 (7.1%) 80 (7.0%) 14 (7.9%) .663
Mixed bacteremia 29 (2.2%) 20 (1.8%) 9 (5.1%) .005
Severity score
SIRS ≥2 867 (65.8%) 734 (64.4%) 133 (74.7%) .007
qSOFA ≥2 197 (14.9%) 145 (12.7%) 60 (33.7%) <.001
CRP=C-reactive protein, PCT=procalcitonin, qSOFA=quick sepsis-related organ failure assessment, SIRS= systemic inflammatory response syndrome.
∗
Data available for 1098 patients.
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h of admission were noted. The endpoint, all-cause inhospital
mortality, was determined by systematically reviewing hospital
records resulting from each patient’s index hospitalization. SIRS
criteria variables include abnormal body temperature, tachycar-
dia, tachypnea, and abnormal white blood cell count. The criteria
for qSOFA include altered mental status, hypotension, or
tachypnea. In addition, we defined septic shock as a systolic
blood pressure <100mm Hg requiring vasopressor therapy, and
respiratory difficulty as a respiratory rate >22breaths/min, an
oxygen saturation <90%, or need for supplemental oxygen by
either face mask or 100% nonrebreather.
2.4. Measurement of PCT and CRP
Blood samples were collected within 24hours of admission. PCT
concentrations were measured using an immunoluminometric
assay with a detection limit of 0.06ng/mL (VIDAS PCT;
bioMerieux, Marcy, France). CRP was measured using an
immunonephelometric assay (Olympus, Osaka, Japan) with a
detection limit of 0.2mg/L.
2.5. Statistical analysis
Chi-square tests for categorical variables and Mann–Whitney U
tests for continuous variables were performed for univariate
comparison. The correlation between serum levels of biomarkers
and clinical severity (defined by SIRS or qSOFA score) was
examined with box plots. To evaluate whether PCT or CRP has
incremental prognostic value independent of qSOFA variables,
we employed a logistic regression model. The values of CRP and
PCT were entered into the model as predefined ordinal scales to
ease clinical application. We categorized the biomarker values
into 3 ordinal classes (0, 1, and 2): 0 was assigned for PCT levels
<0.25 and CRP <60, 1 for PCT levels from 0.25 to 2 and CRP
from 60 to 120, and 3 for PCT >2 and CRP >120. We then
compared the predictive values of SIRS, qSOFA, qSOFA plus
ordinal CRP class (qSOFA_CRP), and qSOFA plus ordinal PCT
class (qSOFA_PCT). The predictive value of each model was first
calculated by the c-statistic, or area under the receiver-operating
characteristic (ROC) curve (AUC), for which larger values
indicate better discrimination. We compared the predicted
probabilities and observed risk in each risk category.[15]
Next, we divided all patients into 4 predicted inhospital
mortality risk groups: very low risk (0% to less than 5%), low
risk (5% to less than 15%), high risk (15% to less than 30%), and
very high risk (30% or greater). We then assessed whether the
biomarker enhanced qSOFA models significantly reclassified
patients into more appropriate mortality risk categories in
comparison with the qSOFA model. The overall reclassification
improvement was evaluated by the net reclassification improve-
ment (NRI) and the integrated discrimination improvement (IDI).
TheNRIwascalculatedby summing theproportionofparticipants
across risk categories whose estimated risk shifts in the correct
direction minus the proportion of participants whose risk shifts in
the incorrect direction.[16–18] Therefore, NRI was used as a
measure to estimate any overall improvement in reclassification
with the newmodel. Rather than using discrete risk categories, the
IDI calculates the difference in discrimination slopes between the 2
models. Consequently, the IDI index demonstrates the improve-
ment in both discrimination and reclassification.
Lastly, we calculated the sensitivity, specificity, positive
predictive value (PPV), and negative predictive value (NPV) of
SIRS, qSOFA, and qSOFA_PCT in predicting inhospital
mortality, and we calibrated each model to mortality rate with
bar graphs.We validate the accuracy of qSOFA and qSOFA_PCT
in an independent historical sample by calculating the sensitivity,
specificity, PPV, and NPV. All analyses were performed with SAS
Version 9.4 (Cary, NC), except for the NRI and IDI statistics,
which were computed with R Statistical Software (Foundation
for Statistical Computing, Vienna, Austria). A 2-sided P value
<.05 was viewed as significant.
2.6. Ethical approval
This study was approved by the institutional review board of
National Taiwan University Hospital.
3. Results
3.1. Patient characteristics and outcome
During the study period, 604 patients from NTUH, 503 from
SCPH, and 515from FSFPH fulfilled the inclusion criteria. After
the exclusion of 304 ICU patients, the final cohort included a total
of 1318 patients (Supplementary eFig. 1, http://links.lww.com/
MD/D28). In all, 867 (65.8%), 208 (15.8%), and 752 (53.1%)
patients were diagnosed with sepsis according to the SIRS criteria
and qSOFA score, respectively. In all, 205 (15.6%) patients had
clinical significant bacteremia, with a higher prevalence of gram-
negative bacteremia (7.1%) than gram-positive bacteremia
(6.1%). The median age of the study sample was 64.0
(interquartile range 47–75) years old. The overall inhospital
mortality rate was 13.5%. The mortality of patients with clinical
significant bacteremia was 19.5%.
Table 1 summarizes the baseline characteristic of patients. In
general, nonsurvivors were older, had a higher burden of
comorbidities and organ dysfunction, had more lower respirato-
ry tract infections, had more bloodstream infection and
polymicrobial infection, and had a greater proportion of patients
with PCT, SIRS, or qSOFA scores higher than reference levels.
3.2. Comparison of correlation of laboratory markers and
qSOFA
Weexamined the correlation between 3 laboratorymarkers (white
blood cell count, CRP, and PCT) and the qSOFA score. The scatter
plots of the 3 markers stratified by the 4 qSOFA classes are shown
in Fig. 1. PCT has the highest correlation with qSOFA class,
followed by CRP and white blood cell (WBC) count.
3.3. Comparison of model performance-discrimination,
model fit, and reclassification
Table 2 also presents comparisons of discrimination, overall fit,
and reclassification statistics for 4 different models. For
discrimination, defined as the AUC, qSOFA_PCT model had
the largest AUC, followed by qSOFA_CRP, qSOFA, and SIRS.
For overall fit, using Bayes information criteria, a lower score
indicates better goodness of model fit with a parsimonious model.
qSOFA_PCT had the best performance, followed by qSOFA,
qSOFA+CRP, and SIRS. For reclassification, we made 2 stage
comparisons. First, when comparing qSOFA to SIRS, both IDI
and NRI showed qSOFA reclassified patients to a more
appropriate mortality risk category than SIRS. Comparing
Yu et al. Medicine (2019) 98:23 www.md-journal.com
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qSOFA_CRP or qSOFA_PCT with qSOFA, we found that
qSOFA_PCT could better reclassify patients as indicated by
significantly higher NRI and IDI. qSOFA_CRP, however, failed
to demonstrate a higher IDI than qSOFA, although the combined
score still had better NRI than qSOFA alone. Using the
qSOFA_PCT score, in all, 752 (53.1%) patients could be
diagnosed with sepsis, in contrast to 208 (15.8%) patients by
qSOFA score alone.
3.4. Model calibration
To visually compare model performance, we constructed bar
graphs in Fig. 2 to present the mortality rate in each severity class
for the 3 models (SIRS, qSOFA, and qSOFA_PCT). qSOFA_PCT
showed the best calibration, followed by qSOFA. The mortality
rate did not correlate with the SIRS classification. We further
calculated the sensitivity, specificity, PPV, and NPV for SIRS,
qSOFA, and qSOFA_PCT for inhospital mortality prediction
(Table 3).We used a cut-off score of≥2 for each criterion. Despite
the poor performance in model fit and calibration, SIRS had the
best sensitivity at the cost of the lowest specificity. qSOFA had the
highest specificity, but lowest sensitivity. qSOFA_PCT ≥2 greatly
enhances the sensitivity of qSOFA to 86.5%with a compromised
specificity of 47.5%.
3.5. Validation
In the validation cohort, we confirmed qSOFA had a suboptimal
sensitivity (39.1%) and high specificity (94.9%) in predicting
30-day mortality. Incorporation of PCT into qSOFA could
improve the sensitivity to 90.9% at the cost of low specificity
(50.3%).
Table 2
The discriminating capability of different laboratory markers in predicting sepsis mortality, presented as the area under curve.
Variables SIRS qSOFA qSOFA_CRP qSOFA_PCT
Area under the ROC curve 0.56 (0.52 to 0.60) 0.67 (0.62 to 0.71) 0.69 (0.64 to 0.73) 0.73 (0.69 to 0.77)
Bayes information criteria 842.63 812.25 815.37 807.09
Integrated discrimination improvement (IDI) NA 0.042 (0.022 to 0.061)
P< .0001
0.0028 (0.0019 to 0.0076)
P= .24
0.0097 (0.0017 to 0.018)
P= .018
Net reclassification improvement (NRI) NA 0.55 (0.38 to 0.72)
P< .0001
0.29 (0.12 to 0.47)
P= .0012
0.35 (0.17 to 0.52) P= .00011
CRP=C-reactive protein, PCT=procalcitonin, qSOFA=quick sepsis-related organ failure assessment, ROC= receiver-operating characteristic, SIRS= systemic inflammatory response syndrome.
Figure 2. Observedmortality rate in SIRS, qSOFA, and PCT enhanced qSOFA severity categories. PCT=procalcitonin, qSOFA=quick sepsis-related organ failure
assessment, SIRS=systemic inflammatory response syndrome.
Figure 1. Serum levels of white blood cell count, CRP, and PCT in patients with different qSOFA severity classifications. CRP=C-reactive protein, PCT=
procalcitonin, qSOFA=quick sepsis-related organ failure assessment.
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4. Discussion
In our retrospective validation of the Sepsis-3 definitions using
multicenter cohorts, we confirmed that the qSOFA score is
superior in mortality prediction compared with SIRS in terms of
discrimination, model fit, reclassification, and calibration statis-
tics. We also demonstrated that PCT has better correlation with
clinical severity thanWBC count or CRP. Furthermore, we found
that combining PCT and the qSOFA score by simply adding the
ordinal scale of PCT to the qSOFA score can significantly
enhance its mortality prediction capability in all dimensions of
model performance indicators. Clinically, PCT enhanced qSOFA,
or qSOFA_PCT, has the best sensitivity (86.5%) and can be
served as a screening tool to quickly identify patients with sepsis
who may benefit from early intervention. qSOFA alone has the
best specificity (87.0%) and can subsequently serve as a quick
confirmation tool to aid in the decision to pursue more invasive
treatment.
The original Sepsis-3 definitions proposed using the simple
qSOFA score as the initial screening tool, followed by the
comprehensive SOFA score as the confirmation tool for sepsis. In
the original work, the sensitivity of a qSOFA score ≥2 was
reported to be low at 55%, albeit with a high specificity (84%),
whereas a change of SOFA score of ≥2 had a higher sensitivity
(68%), but a lower specificity (67%). The sensitivity and
specificity profiles of qSOFA and SOFA, however, are contradic-
tory to their proposed clinical use. A screening tool requires high
sensitivity, whereas a confirmation tool requires high specificity.
Our study, like other external validation studies, confirmed the
low sensitivity and high specificity of the qSOFA score.[19]
Thus, we propose incorporating PCT levels into qSOFA to
correct for its low sensitivity. The high sensitivity (86.5%) and
high NPV (95.8%) of qSOFA_PCT≥2 justify the combined score
as an initial screening tool. Nonetheless, we would like to
preserve the qSOFA as a confirmation tool for 2 reasons. First, it
is validated as a simple but highly specific tool with a specificity
(84%) higher than the proposed delta SOFA greater than 2
(specificity 67%). Second, in clinical settings outside the ICU such
as the ED, the comprehensive SOFA score may not be easily
obtained. In summary, we believe the newly proposed algorithm,
using high-sensitivity qSOFA_PCT as a screening tool and the
high-specificity qSOFA score as the confirmation tool, is the most
optimal use of biomarker information and the best clinical
decision rule in clinical settings outside of the ICU.
In addition to the contradiction between the sensitivity and
specificity profiles of qSOFA and SOFA, another major concern
regarding replacing SIRS with qSOFA is the absence of clinical
indicators of infection in the qSOFA score.[20] PCT has been
shown to be a reasonably sensitive marker in differentiating
sepsis from sterile SIRS. In a large meta-analysis with 3244
patients, PCT alone had a sensitivity of 77% and a specificity of
79% in the diagnosis of sepsis.[21] The accuracy of PCT has been
shown to be valid for various sites of infection and for different
populations such as the elderly, patients with renal impairment,
and patients with autoimmune disease.[22–25] Therefore, the
addition of PCT to the qSOFA score may complement its lack of
infection indicators. However, the accuracy of PCT may be
compromised in patients with neutropenia, hyperfunctioning
thyroid cancer, and in patients with certain subacute infectious
diseases such as infective endocarditis.[26–29] The qSOFA_PCT
should be used cautiously in these specific populations.
In clinical settings where testing for PCT is not readily
available, the SIRS criteria would retain its value as a simple
and low-cost screening tool. In multiple validation studies, SIRS
≥2 consistently demonstrates a higher sensitivity than qSOFA.
We thus propose that when PCT cannot be obtained, SIRS
should remain as a screening tool with qSOFA as the
confirmation tool.
Although we showed that the AUC of qSOFA_PCT is higher
than qSOFA alone, the confidence intervals overlapped. The
limitations of the c-statistic, or AUC, as a measure of clinical
model performance, have been discussed extensively in the
literature. AUC is based exclusively on ranks, and it only
measures how well the predicted values can rank order the
responses.[30,31] It may not be as sensitive as the likelihood
function in choosing between models, and it is less clinically
relevant as a calibration measure that directly cross-classifies the
predicted risk categories with the observed risk. The magnitude
of IDI, defined as the difference in discrimination slopes, has a
direct interpretation.[32] In our study, qSOFA_PCT, compared
with qSOFA, had an IDI of 0.0097. This indicates that the new
model increases the mean difference of predicted probabilities for
death and nondeath by 0.97%. In the reclassification analysis,
NRI is calculated as the sum of the net percentages of correctly
reclassified patients with and without the event of interest. NRI is
the favored metric when assessing the true discriminatory
potential of a new predictor compared with other predictors.
It captures the incremental strength of the new predictor after
accounting for correlations with variables included in the
baseline model. NRI values above 0.6 are considered strong,
0.4 intermediate, and below 0.2 weak. In our case, the NRI
comparing qSOFA_PCT with qSOFA is 0.35, which suggests a
medium number of patients were reclassified to more appropriate
risk categories. This change was found to be significant
(P= .00011).
Since its publication of Sepsis-3 criteria and qSOFA in 2016,
numerous attempts have been made to assess the performance of
Table 3
Comparison of the sensitivity and specificity of SIRS, qSOFA, and qSOFA_PCT in predicting inhospital mortality.
Variables Sensitivity Specificity PPV NPV
Derivation cohort
SIRS ≥2 74.7% (67.7%–80.9%) 35.6% (32.8%–38.5%) 15.3% (14.1%–16.6%) 90.0% (87.4%–92.2%)
qSOFA ≥2 32.6% (25.8%–40.0%) 87.0% (87.3%–91.0%) 29.4% (24.3%–35.2%) 89.3% (88.3%–90.3%)
qSOFA_PCT ≥2 86.5% (80.6%–91.2%) 47.5% (44.6%–50.5%) 20.5% (19.2%–21.8%) 95.8% (93.9%–97.1%)
Validation cohort
SIRS ≥2 70.5% (54.8%–83.2%) 43.2% (38.5%–48.0%) 11.2% (9.3%–13.4%) 93.5% (90.0%–95.9%)
qSOFA ≥2 39.1% (25.1%–54.6%) 94.9% (92.4%–96.8%) 42.1% (24.3%–35.2%) 93.7% (88.3%–90.3%)
qSOFA_PCT ≥2 90.9% (78.3%–97.5%) 50.3% (45.5%–55.1%) 15.6% (14.0%–17.5%) 98.2% (95.5%–99.3%)
Yu et al. Medicine (2019) 98:23 www.md-journal.com
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qSOFA. A recent meta-analysis collecting 45 studies showed low
sensitivity and good specificity when the qSOFA is used as a
screening tool for sepsis (pooled sensitivity was 61%, and
specificity was 72%).[33] In contrast, SIRS criteria resulted in a
pooled sensitivity of 88%, but with only 26% specificity. Our
study demonstrates that combing PCT and qSOFA, rather than
PCT and SIRS, can achieve the best sensitivity. The simple
qSOFA_PCT score will help clinicians identify at-risk patients
and those with high likelihood for deterioration. A prospective
external validation of this simple score is needed to verify the
generalizability of this modified score.
Our work has both strengths and limitations. We were the first
in the literature to prove the added prognostic value of PCT to the
qSOFA score by a rigorous statistical analysis. We further
proposed a practical strategy for clinical use: the highly sensitive
qSOFA_PCT score used as a screening tool, followed by the
highly specific qSOFA score used as the confirmation tool. In
addition, this multicenter design has a relatively large population,
which increases the generalizability of our work. A key limitation
of our study was the retrospective nature of this work. However,
the patient characteristics of our study cohort are comparable
with prospectively collected continuous samples. In addition, as
these sepsis patients were not enrolled in ICU, common severity
scores such as SAPS, APACHE II, or SOFA score were not
available.
5. Conclusions
Our work confirmed that qSOFA has low sensitivity and high
specificity in predicting sepsis mortality. The incorporation of the
ordinal scale of PCT to the qSOFA model could enhance
sensitivity and reclassify patients into risk groups that better
reflect their actual short-term mortality risk. We propose using
qSOFA_PCT as a screening tool followed by qSOFA alone as a
confirmation tool for the identification of patients with sepsis in
settings outside of the ICU.
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